Chagas Disease in the U.S. (What United States Health Care Providers Need To Know About Chagas Disease)
COURSE NUMBER: WB4052R
PROGRAM DESCRIPTION: This activity will inform health care providers about Chagas disease including manifestations and transmission modes with example cases to relate to their own patient experiences.
This course is designed to educate clinicians about Chagas disease in the United States. Lesson 1 covers basic epidemiology, including a detailed life cycle of Trypanosoma cruzi (the causative agent) and risk factors for acquiring the disease. Lesson 2 discusses phases and manifestations of Chagas disease. Lesson 3 covers laboratory diagnosis, clinical evaluation, and treatment options. This course also includes 3 patient scenarios, to present an opportunity to think critically about diagnosis and treatment of Chagas disease.
OBJECTIVES:
After completion of the course, participants will be able:
- Describe Chagas disease epidemiology, life cycle of Trypanosoma cruzi, and risk factors for acquiring the disease.
- Describe the phases and manifestations of Chagas disease.
- Describe features of the disease in immunocompromised hosts.
- Describe the laboratory options for diagnosis.
- Describe an effective clinical evaluation of the newly diagnosed patient
- Describe current recommendations for antitrypanosomal treatment.
FACULTY/CREDENTIAL:
Susan P. Montgomery, DVM MPH, Veterinary Medical Officer, Centers for Disease Control and Prevention
ORIGINATION DATE: September 01, 2018
CE RENEWAL DATE: September 01, 2020
EXPIRATION DATE: September 01, 2022
URL: https://www.cdc.gov/parasites/cme/chagas/course1.html
HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser
MATERIALS: None
TARGET AUDIENCE: Physicians, Registered Nurses
PREREQUISITES: None
FORMAT: Enduring Materials
CONTACT INFORMATION: Parasitic Diseases Branch (404) 718-4745
ACCREDITATION STATEMENTS
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this enduring material for a maximum of (1.25) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides (1.0) contact hours.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Susan P. Montgomery’s discussion of Nifurtimox, which is not FDA approved. CDC has FDA permission to release nifurtimox under IND mechanisms for compassionate use in the United States.
CDC did not accept commercial support for this continuing education activity.
Launch Course
Instructions for Obtaining Continuing Education (CE)
In order to receive continuing education (CE) for WB4052R – Chagas Disease in the U.S. (What United States Health Care Providers Need To Know About Chagas Disease) please visit TCEO and follow these 9 Simple Steps before September 01, 2022.
- Complete the activity
- Complete the Evaluation at www.cdc.gov/GetCE
- Pass the posttest at 80% at www.cdc.gov/GetCE
FEES: No fees are charged for CDC’s CE activities.